vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and EVOLUTION PETROLEUM CORP (EPM). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $19.2M, roughly 1.1× Apyx Medical Corp). EVOLUTION PETROLEUM CORP runs the higher net margin — 5.2% vs -6.8%, a 11.9% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 2.0%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -5.2%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
APYX vs EPM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $19.2M | $20.7M |
| Net Profit | $-1.3M | $1.1M |
| Gross Margin | 62.6% | 44.3% |
| Operating Margin | 0.1% | 3.2% |
| Net Margin | -6.8% | 5.2% |
| Revenue YoY | 34.7% | 2.0% |
| Net Profit YoY | 71.9% | 158.4% |
| EPS (diluted) | — | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $20.7M | ||
| Q3 25 | $12.9M | $21.3M | ||
| Q2 25 | $11.4M | $21.1M | ||
| Q1 25 | $9.4M | $22.6M | ||
| Q4 24 | $14.2M | $20.3M | ||
| Q3 24 | $11.5M | $21.9M | ||
| Q2 24 | $12.1M | $21.2M | ||
| Q1 24 | $10.2M | $23.0M |
| Q4 25 | $-1.3M | $1.1M | ||
| Q3 25 | $-2.0M | $824.0K | ||
| Q2 25 | $-3.8M | $3.4M | ||
| Q1 25 | $-4.2M | $-2.2M | ||
| Q4 24 | $-4.6M | $-1.8M | ||
| Q3 24 | $-4.7M | $2.1M | ||
| Q2 24 | $-6.6M | $1.2M | ||
| Q1 24 | $-7.6M | $289.0K |
| Q4 25 | 62.6% | 44.3% | ||
| Q3 25 | 64.4% | 38.5% | ||
| Q2 25 | 62.3% | 46.1% | ||
| Q1 25 | 60.1% | 40.7% | ||
| Q4 24 | 63.0% | 36.9% | ||
| Q3 24 | 60.5% | 46.2% | ||
| Q2 24 | 61.7% | 46.3% | ||
| Q1 24 | 58.1% | 45.2% |
| Q4 25 | 0.1% | 3.2% | ||
| Q3 25 | -6.5% | -0.4% | ||
| Q2 25 | -22.6% | 6.3% | ||
| Q1 25 | -32.4% | 7.0% | ||
| Q4 24 | -21.4% | -3.0% | ||
| Q3 24 | -31.6% | 8.5% | ||
| Q2 24 | -45.7% | 11.3% | ||
| Q1 24 | -64.6% | 9.1% |
| Q4 25 | -6.8% | 5.2% | ||
| Q3 25 | -15.4% | 3.9% | ||
| Q2 25 | -33.2% | 16.2% | ||
| Q1 25 | -44.0% | -9.7% | ||
| Q4 24 | -32.5% | -9.0% | ||
| Q3 24 | -40.9% | 9.4% | ||
| Q2 24 | -54.0% | 5.8% | ||
| Q1 24 | -74.0% | 1.3% |
| Q4 25 | — | $0.03 | ||
| Q3 25 | — | $0.02 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | $-0.19 | $0.04 | ||
| Q1 24 | $-0.22 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $3.8M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $67.5M |
| Total Assets | $66.8M | $169.3M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $3.8M | ||
| Q3 25 | $25.1M | $714.0K | ||
| Q2 25 | $29.3M | $2.5M | ||
| Q1 25 | $31.0M | $5.6M | ||
| Q4 24 | $31.7M | $11.7M | ||
| Q3 24 | $28.0M | $6.9M | ||
| Q2 24 | $32.7M | $6.4M | ||
| Q1 24 | $37.3M | $3.1M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $67.5M | ||
| Q3 25 | $5.8M | $69.1M | ||
| Q2 25 | $7.3M | $71.8M | ||
| Q1 25 | $10.5M | $71.7M | ||
| Q4 24 | $14.2M | $76.3M | ||
| Q3 24 | $11.0M | $79.6M | ||
| Q2 24 | $14.7M | $81.1M | ||
| Q1 24 | $20.3M | $83.5M |
| Q4 25 | $66.8M | $169.3M | ||
| Q3 25 | $57.4M | $169.1M | ||
| Q2 25 | $58.2M | $160.3M | ||
| Q1 25 | $60.2M | $156.4M | ||
| Q4 24 | $64.8M | $160.2M | ||
| Q3 24 | $60.7M | $157.9M | ||
| Q2 24 | $65.4M | $162.9M | ||
| Q1 24 | $70.7M | $166.5M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $5.4M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 5.09× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $5.4M | ||
| Q3 25 | $-3.5M | $7.8M | ||
| Q2 25 | $-1.2M | $10.5M | ||
| Q1 25 | $-702.0K | $7.3M | ||
| Q4 24 | $-2.9M | $7.7M | ||
| Q3 24 | $-4.4M | $7.6M | ||
| Q2 24 | $-4.3M | $8.0M | ||
| Q1 24 | $-6.3M | $3.4M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | 5.09× | ||
| Q3 25 | — | 9.47× | ||
| Q2 25 | — | 3.06× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.69× | ||
| Q2 24 | — | 6.47× | ||
| Q1 24 | — | 11.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |